Stock Alerts
Selling Boeing shares on the President’s tariff announcement
I don't think there's any point to waiting around to see how quickly or fiercely China (and the European Union) will retaliate against U.S. exporters after today's announcement that the United States will put a 25% tariff on Chinese (and other imported) steel and a...Adding Pioneer Natural Resources call options for January 18, 2019 at $180 to my Volatility Portfolio
I'm adding call options in a Permian Basin oil shale producer, Pioneer Natural Resources (PXD). I think the oil market is a good candidate for disruption in 2018 either from OPEC's efforts to drive the price of oil above $70 or from an outbreak of conflict in the...
Selling MGM March 16 calls out of my Volatility Portfolio
Shares of MGM Resorts International (MGM) rose 2.52% on Friday, February 23, to close at $35.38. I'm going to use that move to the upside to sell my March 16, 2018 MGM calls (MGM180316C00033000) out of my Volatility Portfolio. I bought these options back on September...
Buying call Nektar options at $90 for August 17, 2018 expiration in my Volatility Portfolio
When I started my rebalancing of my Volatility Portfolio on February 20, I thought I would add the slightly in the money Nektar Therapeutics (NKTR) calls at $80 with an expiration of August 17, 2018 at a closing price of $18.50. But the underlying stock has moved up...
To rebalance my Volatility Portfolio I’m selling my Nektar May 18 call options
I'm not complaining, mind you. As of Friday February 23, the Nektar Therapeutics May 18, 2018 call options with a strike of $26 (NKTR180518C00026000) in my Volatility Portfolio were up 2546% from my November 1, 2017 buy at $2.40 to $63.50. But I don't want to have...
Big earnings report from MGM Resorts before the market open tomorrow
Tomorrow's earnings report from MGM Resorts International (MGM) could be make or break for the call options that I hold on this stock in my Volatility Portfolio. The options have been all over the block in recent weeks from up 50% to down 30% on market volatility and...
Bristol-Myers puts up potential $3.6 billion in deal for 35% of a Nektar cancer drug
In the deal announced today Bristol-Myers Squibb (BMY) pays Nektar Therapeutics $1 billion upfront, $850 million for stock valued at a price of $102 a share, and a potential $1.78 billlion in milestone payments in exchange for access to NKTR 214, a drug candidate still in trials and that has shown the ability to extend the range of Bristol-Myers Opdivo
Diamondback Energy beats on earnings and starts dividend
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
Adding an ETF to short Treasuries to my Volatility Portfolio
As I write this at 3:50 p.m. New York time, the Dow Jones Industrial Average is down 646 points or 2.47%. The Standard & Poor's 500 Stock Index is off 1.92% or 54.32 points. The NASDAQ Composite is down 1.89% and the Russell 2000 small cap index is lower by 1.72%....
PayPal beats on earnings and revenue, but falls after hours on profit taking
PayPal Holdings (PYPL) reported fourth quarter earnings of 55 cents a share, 3 cents a share above Wall Street estimates, and revenue of $3.71 billion (on a foreign-exchange neutral basis) vs projections for $3.63 billion. Revenue climbed 24% year over year for the...
Corning drops on accounting loss from tax cut bill
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Jim’s Stock Alerts
Download Jim’s eBook for Free
